Improved Clinical Symptoms and Mortality among Patients with Severe or Critical COVID-19 after Convalescent Plasma Transfusion.

Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.